.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Merck
Baxter
Deloitte
Boehringer Ingelheim
Medtronic
Cerilliant
Novartis
McKinsey

Generated: June 24, 2017

DrugPatentWatch Database Preview

ADIPEX-P Drug Profile

« Back to Dashboard

What is the patent landscape for Adipex-p, and what generic Adipex-p alternatives are available?

Adipex-p is a drug marketed by Teva and is included in two NDAs.

The generic ingredient in ADIPEX-P is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.

Summary for Tradename: ADIPEX-P

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list19
Clinical Trials: see list2
Patent Applications: see list632
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ADIPEX-P at DailyMed

Pharmacology for Tradename: ADIPEX-P

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
ADIPEX-P
phentermine hydrochloride
CAPSULE;ORAL088023-001Aug 2, 1983AARXNoYes► Subscribe► Subscribe
Teva
ADIPEX-P
phentermine hydrochloride
TABLET;ORAL085128-001Approved Prior to Jan 1, 1982AARXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Merck
Medtronic
Cantor Fitzgerald
Colorcon
QuintilesIMS
Cipla
Express Scripts
Fish and Richardson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot